Cooperative Agreement U01PS005290
- The U.S. Centers for Disease Control and Prevention (CDC) awarded a $250,000 Cooperative Agreement to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award, effective September 1, 2025 through August 31, 2030, will support the "RAPID-CYCLE SURVEY COLLABORATIVE FOR PUBLIC AND PROVIDER INPUT ON IMMUNIZATION ISSUES: VACCINE POLICY COLLABORATIVE INITIATIVE."...
- This $4,652,515 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC), under the Grants to States for Medicaid (CFDA 93.778) program, is funding the Chicago Department of Public Health (CDPH) to strengthen vaccine-preventable disease prevention and response. The funding period is from July 1, 2025 to June 30, 2030. Through this award, CDPH will deliver a range of critical public health services and interventions, including community health worker training, HIV and...
- The University of California, San Diego (UCSD) was awarded a $2,911,005 Project Grant from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to conduct a retrospective study evaluating the impact of public health activities related to the HIV care continuum in New York City. The project, titled "CHROME: Continuum of HIV Response through Observational Molecular Epidemiology", aims to determine if individuals without...
- This Cooperative Agreement award, provided by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) under CFDA 93.940 - HIV Prevention Activities Health Department Based, will enable the Colorado Department of Public Health & Environment (CDPHE) to strategically direct $920,142 in funding to reduce tuberculosis (TB) morbidity and mortality. The key objectives are to: (1) identify and fully treat persons with active TB disease; (2) treat individuals...
- This Project Grant award from the Department of Health and Human Services' National Institutes of Health (CFDA 93.310 - Trans-NIH Research Support) provides $703,644 to the Icahn School of Medicine at Mount Sinai to investigate the drivers of accelerated aging in people living with HIV (PWH). The research aims to study the effects of HIV and antiretroviral therapy on epigenetic aging and clonal hematopoiesis, as well as examine the role of socio-behavioral factors and genetic predisposition in...
- This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $793,247 to the University of North Carolina at Chapel Hill to conduct research aimed at improving the health of people living with HIV across the lifespan. The key products and services to be delivered include: Developing and implementing a data-driven algorithm to assign validated causes for hospitalizations among people with HIV, and using...
- This Project Grant award of $429,000.00 from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Colorado-Denver aims to investigate the relationship between gut microbiota dynamics, exercise, and physical function among older adults with HIV. The research project will examine how exercise-induced changes in the gut microbiome may contribute to improvements in physical function for this population, which has been observed to experience impairments in physical...
- The Indiana Department of Health (IDOH) was awarded a $1,493,636 Cooperative Agreement by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). This five-year award, effective January 1, 2025 through December 31, 2029, will support comprehensive efforts to prevent, diagnose, and manage HIV and tuberculosis (TB) in Indiana. The funding will allow IDOH to implement high-impact prevention and surveillance...
- The Chicago Department of Public Health (CDPH) received a $1,468,102 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). This 5-year award, valid from January 1, 2025 to December 31, 2029, supports CDPH's comprehensive efforts to prevent, diagnose, and manage HIV and tuberculosis (TB) in the city of Chicago. The key products and services delivered through this Cooperative Agreement...
This $1,015,194 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Prevention of Disease, Disability, and Death by Infectious Diseases program (CFDA 93.084) supports research at the University of Colorado-Denver to understand integrative care and support pathways to healthy aging for adults aging with HIV. The 3-year project, which runs from September 30, 2025 to September 29, 2028, aims to develop innovative strategies for addressing the complex medical and psychosocial needs of this population. The research will leverage the university's expertise in translational research, medical investigations, and specialized scientific studies to advance understanding and improve care approaches for adults aging with HIV.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.0m | 9/24/25 |